Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 164,331 |
|
|||||
| News | - | ||||||
| Day High | 0.81 | Low High |
|||||
| Day Low | 0.7801 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| AlloVir Inc | ALVR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0085 | -1.05% | 0.798 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.81 | 0.7801 | 0.81 | 0.798 | 0.8065 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,134 | 164,331 | $ 0.7945937 | $ 130,576 | - | 0.6231 - 6.12 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:52:45 | 1 | $ 0.8045 | USD |
AlloVir Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 91.25M | 114.06M | - | 0 | -190.42M | -1.67 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
AlloVir News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ALVR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.7801 | 0.8186 | 0.7701 | 0.8044248 | 184,391 | 0.0179 | 2.29% |
| 1 Month | 0.762 | 0.825 | 0.7057 | 0.7644185 | 318,667 | 0.036 | 4.72% |
| 3 Months | 0.6844 | 0.85 | 0.6425 | 0.7408578 | 561,107 | 0.1136 | 16.60% |
| 6 Months | 1.75 | 2.485 | 0.6231 | 0.9324481 | 1,395,086 | -0.952 | -54.40% |
| 1 Year | 3.73 | 6.12 | 0.6231 | 1.64 | 1,062,712 | -2.93 | -78.61% |
| 3 Years | 23.81 | 26.41 | 0.6231 | 4.89 | 674,586 | -23.01 | -96.65% |
| 5 Years | 22.82 | 48.96 | 0.6231 | 7.90 | 605,205 | -22.02 | -96.50% |
AlloVir Description
| AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases. The firm's pipeline includes ALVR106, ALVR109, ALVR108, and others. The company's product candidate, Viralym-M, is a multi-VST therapy targeting five viruses namely BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, and human herpesvirus 6. |
